Evidence map›Paper›PMID 36707886›Full record

ArticleMalaria journal2023

Multi-country evaluation of the durability of pyrethroid plus piperonyl-butoxide insecticide-treated nets: study protocol.

Emmanuel Mbuba, Olukayode G Odufuwa, Jason Moore, Selemani Mmbaga, Emile Tchicaya, Constant Edi, Vani Chalageri, Sreehari Uragayala, Amit Sharma, Manju Rahi and 5 more

Open access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in Malaria journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Durability study of VeeralinParasites & vectors · 2025
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 6 countries.

Emmanuel MbubaVector Control Product Testing Unit, Environmental Health and Ecological Science, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania. embuba@ihi.or.tz.
Olukayode G OdufuwaVector Control Product Testing Unit, Environmental Health and Ecological Science, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania.
Jason MooreVector Control Product Testing Unit, Environmental Health and Ecological Science, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania.
Selemani MmbagaVector Control Product Testing Unit, Environmental Health and Ecological Science, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania.
Emile TchicayaSwiss Centre for Scientific Research in Côte d'Ivoire, 1303, Abidjan, Côte d'Ivoire.
Constant EdiSwiss Centre for Scientific Research in Côte d'Ivoire, 1303, Abidjan, Côte d'Ivoire.
Vani ChalageriField Unit, ICMR-National Institute of Malaria Research, Bangalore, Karnataka, India.
Sreehari UragayalaField Unit, ICMR-National Institute of Malaria Research, Bangalore, Karnataka, India.
Amit SharmaICMR-National Institute of Malaria Research, Sector-8, Dwarka, New Delhi, 110077, India.
Manju RahiICMR-Indian Council of Medical Research, Ansari Nagar, New Delhi, India.
Kamaraju RaghavendraICMR-National Institute of Malaria Research, Sector-8, Dwarka, New Delhi, 110077, India.
Alex EapenField Unit, ICMR-Indian Council of Medical Research, Chennai, India.
Hannah KoenkerTropical Health LLP, Baltimore, USA.
Amanda RossSwiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123, Allschwil, Switzerland.
Sarah J MooreVector Control Product Testing Unit, Environmental Health and Ecological Science, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania.
National Institute of Malaria Research · INUniversity of Basel · CHIfakara Health Institute · TZIndian Council of Medical Research · INSwiss Centre for Scientific Research · CISwiss Tropical and Public Health Institute · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMass distributions of long-lasting insecticidal nets (LLINs) have contributed to large reductions in the malaria burden. However, this success is in jeopardy due in part to the increasing pyrethroid-resistant mosquito population as well as low LLINs coverage in various areas because the lifespan of LLINs is often shorter than the interval between replenishment campaigns. New insecticide-treated nets (ITNs) containing pyrethroid and piperonyl-butoxide (PBO) have shown a greater reduction in the incidence of malaria than pyrethroid LLINs in areas with pyrethroid-resistant mosquitoes. However, the durability (attrition, bio-efficacy, physical integrity and chemical retainment) of pyrethroid-PBO ITNs under operational settings has not been fully characterized. This study will measure the durability of pyrethroid-PBO ITNs to assess whether they meet the World Health Organization (WHO) three years of operational performance criteria required to be categorized as "long-lasting".

methodsA prospective household randomized controlled trial will be conducted simultaneously in Tanzania, India and Côte d'Ivoire to estimate the field durability of three pyrethroid-PBO ITNs (Veeralin®, Tsara® Boost, and Olyset® Plus) compared to a pyrethroid LLIN: MAGNet®. Durability monitoring will be conducted up to 36 months post-distribution and median survival in months will be calculated. The proportion of ITNs: (1) lost (attrition), (2) physical integrity, (3) resistance to damage score, (4) meeting WHO bio-efficacy (≥ 95% knockdown after 1 h or ≥ 80% mortality after 24 h for WHO cone bioassay, or ≥ 90% blood-feeding inhibition or ≥ 80% mortality after 24 h for WHO Tunnel tests) criteria against laboratory-reared resistant and susceptible mosquitoes, and insecticidal persistence over time will be estimated. The non-inferiority of Veeralin® and Tsara® Boost to the first-in-class, Olyset® Plus will additionally be assessed for mortality, and the equivalence of 20 times washed ITNs compared to field aged ITNs will be assessed for mortality and blood-feeding inhibition endpoints in the Ifakara Ambient Chamber Test, Tanzania.

conclusionThis will be the first large-scale prospective household randomized controlled trial of pyrethroid-PBO ITNs in three different countries in East Africa, West Africa and South Asia, simultaneously. The study will generate information on the replenishment intervals for PBO nets.

Indexed as

Insecticide-Treated BednetsMalariaPiperonyl ButoxidePyrethrinsAnimalsCote d'IvoireHumansInsecticide ResistanceMosquito ControlProspective StudiesRandomized Controlled Trials as TopicTanzaniaPiperonyl ButoxidePyrethrinsDurabilityInsecticide-treated netsMAGNet®Olyset® plusPiperonyl-butoxideTsara® BoostVeeralin®

Identifiers

PMID36707886
PMCPMC9881340
OpenAlexW4318316272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.